preclinical white papers and articles

  1. Changes In Blood Vessels Shown Through Retinal Scans Could Indicate Early Stages Of Alzheimer's 8/2/2021

    When you hear “retinal scan,” you might picture biometric security software – almost like something out of a James Bond film. However, a new study shows that retinal scans could serve as a means for understanding Alzheimer’s disease. To find out more, read the available blog.

  2. Top Three Sources Of Evidence Suggesting Natural Killer Cells Role In Parkinson's Prevention 8/2/2021

    According to the Global Burden of Disease study, 6.2 million patients live with Parkinson’s disease (PD) and this number is expected to double by 2040. To find out more, read the available blog post.

  3. Human Immune System Beats HIV For The First Time 8/2/2021

    The Centers for Disease Control and Prevention (CDC) describes human immunodeficiency virus (HIV) as a virus that attacks the body’s immune system. Without treatment, HIV can cause acquired immunodeficiency syndrome (AIDS). Read the available blog post to find out more.

  4. New Approaches To Antifungal Therapies Hope To Push New Drugs To Market In The Near Future 8/2/2021

    Millions of fungal species live in soil, grow on plants, not to mention on our bodies. Every inhalation can introduce fungal spores. To find out how this happens, read the available blog post.

  5. Gene Therapy Startup Uses Horses To Test Possible Osteoarthritis Therapy 8/2/2021

    Osteoarthritis is a debilitating and painful wearing down of joint cartilage tissues. Every year, more than three million people in the U.S. (and millions more worldwide) are diagnosed with the disease. Read the available blog to find out more.

  6. New Eye Color Genetics Research Could Revolutionize Eye Disease Treatment 8/2/2021

    A new study cited in Science Daily suggests that the genetics of human eye color may be much more complex than previously thought. Interestingly, this study could have implications that go far beyond eye color.

  7. A CRO's Way Forward In The Midst Of A Pandemic: QPS Operations And COVID-19 6/18/2021

    In this Q&A, QPS Holdings LLC Chairman President, and CEO, Ben Chien, Ph.D., reflects on the progress of the company’s growth from a small, three-person start-up to a mid-sized CRO, the impact COVID-19 has had on drug development and clinical trials, and the way forward for CROs in the midst of a pandemic.

  8. The Most Effective COVID-19 Vaccine Could Be Intranasal 6/17/2021

    Vaccine developers are looking at preventing the coronavirus from being transmitted by focusing on the nose and respiratory tract. An intranasal vaccine would trigger immune responses in the nose, throat and lung mucosa by targeting immunoglobulin A (IgA), antibodies which exist solely in the mucosa. The mucosa acts as a physical barrier to potential pathogens, trapping them before they have a chance to enter the body. Given this, the intranasal vaccine would prevent transmission from exhaled droplets or aerosols, as there would not be virus in the body to exhale.

  9. Covid-19 And Brain Fog: How Some Infections Affect The Neurological System 6/17/2021

    Difficulty thinking, concentrating, and remembering are amongst the most debilitating long-haul symptoms of COVID-19. In some cases, this “brain fog” can linger for months. New research helps explain how SARS-CoV-2, the virus that causes COVID-19, spreads to the brain and why some patients experience severe neurological symptoms while others do not.

  10. New Insight Into RNA And DNA Relationship Could Lead To New Antivirals 6/13/2021

    RNA viruses are known to cause a large number of diseases in humans, including COVID-19. One potentially valuable drug development avenue is identifying a mechanism that could halt the function of viral RNA polymerase (RNAP) — the enzyme that initiates RNA replication and thus propagates RNA viruses. In this blog review how a team from the University of Turku, Finland, and Penn State University discovered not only how viral RNA polymerase is triggered, but also how it avoids using DNA nucleotide building blocks, which are chemically similar to RNA.